AMRN insider trading
NasdaqCM HealthcareAMARIN CORP PLC\UK — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About AMARIN CORP PLC\UK
Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally through wholesalers, selected regional wholesalers, and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Company website: www.amarincorp.com
AMRN insider activity at a glance
FilingIQ has scored 1,068 insider transactions for AMRN since Jul 6, 2015. The most recent filing in our index is dated Apr 18, 2026.
Across the full history, 16 open-market purchases
and 120 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on AMRN insider trades is 62.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest AMRN Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for AMRN?
- FilingIQ tracks 1,068 Form 4 insider transactions for AMRN (AMARIN CORP PLC\UK), covering filings from Jul 6, 2015 onwards. 24 of those were filed in the last 90 days.
- Are AMRN insiders net buyers or net sellers?
- Across the full Form 4 history for AMRN, 16 transactions (1%) were open-market purchases and 120 (11%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does AMRN insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is AMRN in?
- AMARIN CORP PLC\UK (AMRN) is classified in the Healthcare sector, specifically Drug Manufacturers - General, with a current market capitalisation of $326.13M.
Methodology & sources
Every AMRN insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.